Inovio Pharmaceuticals (INO) Insider & Congress Trades

Smart money at a glance

Filings to Nov 13, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about INO filings

Are insiders buying or selling Inovio Pharmaceuticals Inc (INO) stock?

Neither. Inovio Pharmaceuticals Inc (INO) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded INO recently?

None. No member of Congress disclosed a INO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this INO smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

FMFmrQ3 2026 13FAdded$11.2M

13F: filed up to 45 days late.

Smart money on INO

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Congress
No recent politician filings found
Funds
- FMR LLC, added +$11.2M, holdings at Sep 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about INO filings

Are insiders buying or selling Inovio Pharmaceuticals Inc (INO) stock?

Neither. Inovio Pharmaceuticals Inc (INO) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded INO recently?

None. No member of Congress disclosed a INO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this INO smart-money data?

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$11.2M

Buys/Adds (1)

FM
FMR LLC
Q3 2026 13F
$11.2M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in 15.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.23-15.74% miss

-$0.20 expected

Revenue

$298.9K

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$0.23est. -$0.20	-15.74%miss	$298.9KSEC filing	No year-ago quarter
Jun 30, 2026Reported Aug 12, 2026	-$0.07est. -$0.25	+72.00%beat	$0.00SEC filing	No year-ago quarter
Mar 31, 2026Reported May 13, 2026	-$0.31est. -$0.33	+4.71%beat	$0.00SEC filing	-100.0%from $65.3K
Dec 31, 2025Reported Mar 12, 2026	-$0.28est. -$0.34	+19.59%beat	$65.3K · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 10, 2025	-$0.87est. -$0.48	-82.77%miss	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 12, 2025	-$0.61est. -$0.62	+1.61%beat	$0.00SEC filing	-100.0%from $100.8K
Mar 31, 2025Reported May 13, 2025	-$0.51est. -$0.74	+31.08%beat	$65.3KSEC filing	No year-ago quarter
Dec 31, 2024Reported Mar 18, 2025	-$0.60est. -$0.83	+27.88%beat	$217.8K · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $1.37
High: $1.48
Low: $1.30
Prev close: $1.45
52-wk high: $2.72
52-wk low: $0.56
Mkt cap: $265.0M
ROE: -409.9%
Fwd P/E: 16.6x
Beta: 1.73
P/B: 37.2x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 16.58
Market cap: $265M

Valuation

P/B37.18

Quality

Operating margin0.0%
ROE-409.9%
ROA-84.2%

Growth

Beta1.73

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

61balanced

20D volatility

458%annualized

52-week range

$1.48

$0.56$2.72

20D support

$0.60recent floor

20D resistance

$2.17recent ceiling

Returns

5D -9.0%20D +49.6%60D +22.9%

Price vs moving averages

SMA20 +28.8%SMA50 +24.9%SMA200 +16.7%

Volume pace

9.00xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 10, 2026

-$0.23est. -$0.20

-15.74%

$298.9KSEC filing

No year-ago quarter

Jun 30, 2026Aug 12, 2026

-$0.07est. -$0.25

+72.00%

$0.00SEC filing

No year-ago quarter

Mar 31, 2026May 13, 2026

-$0.31est. -$0.33

+4.71%

$0.00SEC filing

-100.0%from $65.3K

Dec 31, 2025Mar 12, 2026

-$0.28est. -$0.34

+19.59%

$65.3K · FYSEC filing

No year-ago quarter

Sep 30, 2025Nov 10, 2025

-$0.87est. -$0.48

-82.77%

$0.00SEC filing

No year-ago quarter

Jun 30, 2025Aug 12, 2025

-$0.61est. -$0.62

+1.61%

$0.00SEC filing

-100.0%from $100.8K

Mar 31, 2025May 13, 2025

-$0.51est. -$0.74

+31.08%

$65.3KSEC filing

No year-ago quarter

Dec 31, 2024Mar 18, 2025

-$0.60est. -$0.83

+27.88%

$217.8K · FYSEC filing

No year-ago quarter

Inovio Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about INO filings

Smart money on INO

Questions about INO filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 15.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Inovio Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about INO filings

Smart money on INO

Questions about INO filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 15.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Inovio Pharmaceuticals Inc

Overview

Questions about INO filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Inovio Pharmaceuticals Inc

Overview

Questions about INO filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.